LON:INS - Instem Share Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Instem PLC Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add GBX 467 +12.00 (+2.64 %) (As of 02/17/2020 04:13 AM ET) Add Compare Today's Range 467Now: GBX 467▼ 46750-Day Range 386MA: GBX 442.71▼ 49552-Week Range 290Now: GBX 467▼ 500Volume746 shsAverage Volume3,909 shsMarket Capitalization£77.63 millionP/E Ratio44.90Dividend YieldN/ABetaN/A ProfileAdvanced ChartInsider TradesHeadlines Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Instem plc provides information technology solutions to the life science market worldwide. The company offers solutions for data collection, management, and analysis to meet the needs of life science and healthcare organizations for data-driven decision making. Its solutions include Provantis, an integrated Windows-based system for organizations and universities that are engaged in non-clinical evaluation studies; submit platform that provides a suite of integrated tools and services for the creation and management of SEND datasets and associated documents for contract research organizations and sponsors; ALPHADAS, an eSource EDC system for early phase clinical trials; Animal Care Information System, an animal management software solution; Logbook, a repository for information; and Toxicology Resource Planning, a toxicology solution for pharmaceutical, chemical, and contract research laboratory corporations. Read More… Industry, Sector and Symbol Stock Exchange LON Industry Healthcare Information Services Sub-IndustryN/A SectorComputer and Technology Current SymbolLON:INS Previous Symbol CUSIPN/A CIKN/A Webhttp://www.instem.com/ Phone+44-1785-825600Debt Debt-to-Equity Ratio17.70 Current Ratio1.08 Quick Ratio1.08Price-To-Earnings Trailing P/E Ratio44.90 Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales£23.90 million Price / Sales3.25 Cash FlowGBX 38.64 per share Price / Cash Flow12.09 Book ValueGBX 104.80 per share Price / Book4.46Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees217 Outstanding Shares16,623,100Market Cap£77.63 million Next Earnings DateN/A OptionableNot Optionable Receive INS News and Ratings via Email Sign-up to receive the latest news and ratings for INS and its competitors with MarketBeat's FREE daily newsletter. LSE:INS Rates by TradingView Instem (LON:INS) Frequently Asked Questions What is Instem's stock symbol? Instem trades on the London Stock Exchange (LON) under the ticker symbol "INS." Has Instem been receiving favorable news coverage? News articles about INS stock have trended somewhat positive on Monday, InfoTrie reports. The research group identifies positive and negative news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Instem earned a coverage optimism score of 1.8 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View News Stories for Instem. Who are some of Instem's key competitors? Some companies that are related to Instem include Bigtincan (BTH), Majesco (MJCO), Exfo (EXF), Aptitude Software Group (APTD), Sumo Group (SUMO), Citadel Group (CGL), Tecsys (TCS), Kape Technologies (KAPE), Alfa Financial Software (ALFA), Frontier Digital (FDV), RMA Global (RMY), Thescore (SCR), GBST (GBT), Proton Power Systems (PPS) and Class (CL1). What other stocks do shareholders of Instem own? Based on aggregate information from My MarketBeat watchlists, some companies that other Instem investors own include Abeona Therapeutics (ABEO), Arca Biopharma (ABIO), Apollo Investment (AINV), Alico (ALCO), Corindus Vascular Robotics (CVRS), Delta Apparel (DLA), Document Security Systems (DSS), Evans Bancorp (EVBN), LGL Group (LGL) and NovaBay Pharmaceuticals (NBY). Who are Instem's key executives? Instem's management team includes the folowing people: Mr. Phil J. Reason, CEO & Exec. Director (Age 57)Mr. Nigel John Goldsmith, CFO, Sec. & Exec. Director (Age 57)Ms. Marybeth Thompson, Chief Operating OfficerDr. Gordon Smith Baxter Ph.D., Chief Scientific OfficerMr. Gary Mitchell, VP of Global Marketing How do I buy shares of Instem? Shares of INS and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is Instem's stock price today? One share of INS stock can currently be purchased for approximately GBX 467. How big of a company is Instem? Instem has a market capitalization of £77.63 million and generates £23.90 million in revenue each year. Instem employs 217 workers across the globe.View Additional Information About Instem. What is Instem's official website? The official website for Instem is http://www.instem.com/. How can I contact Instem? Instem's mailing address is Diamond Way, Stone Business Park, STONE, ST15 0SD, United Kingdom. The company can be reached via phone at +44-1785-825600. MarketBeat Community Rating for Instem (LON INS)Community Ranking: 1.8 out of 5 ()Outperform Votes: 92 (Vote Outperform)Underperform Votes: 169 (Vote Underperform)Total Votes: 261MarketBeat's community ratings are surveys of what our community members think about Instem and other stocks. Vote "Outperform" if you believe INS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe INS will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/17/2020 by MarketBeat.com StaffFeatured Article: Pattern Day Trader
